These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25499436)

  • 1. New N-aryl-N'-(3-(substituted)phenyl)-N'-methylguanidines as leads to potential PET radioligands for imaging the open NMDA receptor.
    Naumiec GR; Cai L; Pike VW
    Bioorg Med Chem Lett; 2015 Jan; 25(2):225-8. PubMed ID: 25499436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N'-3-(Trifluoromethyl)phenyl Derivatives of N-Aryl-N'-methylguanidines as Prospective PET Radioligands for the Open Channel of the N-Methyl-d-aspartate (NMDA) Receptor: Synthesis and Structure-Affinity Relationships.
    Naumiec GR; Jenko KJ; Zoghbi SS; Innis RB; Cai L; Pike VW
    J Med Chem; 2015 Dec; 58(24):9722-30. PubMed ID: 26588360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist.
    Reddy NL; Hu LY; Cotter RE; Fischer JB; Wong WJ; McBurney RN; Weber E; Holmes DL; Wong ST; Prasad R
    J Med Chem; 1994 Jan; 37(2):260-7. PubMed ID: 8295213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding characterization of N-(2-chloro-5-thiomethylphenyl)-N'-(3-[
    Metaxas A; van Berckel BNM; Klein PJ; Verbeek J; Nash EC; Kooijman EJM; Renjaän VA; Golla SSV; Boellaard R; Christiaans JAM; Windhorst AD; Leysen JE
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00458. PubMed ID: 30784206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and binding characteristics of N-(1-naphthyl)-N'-(3-[(125)I]-iodophenyl)-N'-methylguanidine ([(125)I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation.
    Owens J; Tebbutt AA; McGregor AL; Kodama K; Magar SS; Perlman ME; Robins DJ; Durant GJ; McCulloch J
    Nucl Med Biol; 2000 Aug; 27(6):557-64. PubMed ID: 11056369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of [11C]N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxy-phenyl)-N'-methylguanidine ([11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor.
    Waterhouse RN; Slifstein M; Dumont F; Zhao J; Chang RC; Sudo Y; Sultana A; Balter A; Laruelle M
    Nucl Med Biol; 2004 Oct; 31(7):939-48. PubMed ID: 15464396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro and in vivo evaluation of [11C]methyl-BIII277CL for imaging the PCP-binding site of the NMDA receptor by pet.
    Kokic M; Honer M; Kessler LJ; Grauert M; Schubiger PA; Ametamey SM
    J Recept Signal Transduct Res; 2002; 22(1-4):123-39. PubMed ID: 12503611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of the novel N-methyl-d-aspartate receptor ligand [11C]GMOM in man.
    van der Doef TF; Golla SSV; Klein PJ; Oropeza-Seguias GM; Schuit RC; Metaxas A; Jobse E; Schwarte LA; Windhorst AD; Lammertsma AA; van Berckel BNM; Boellaard R
    J Cereb Blood Flow Metab; 2016 Jun; 36(6):1111-21. PubMed ID: 26661185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of N,N'-diphenyl and N-naphthyl-N'-phenylguanidines as N-methyl-D-aspartate receptor ion-channel ligands.
    Dumont F; Sultana A; Waterhouse RN
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1583-6. PubMed ID: 12039567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in brain distributions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel.
    Fuchigami T; Haradahira T; Fujimoto N; Okauchi T; Maeda J; Suzuki K; Suhara T; Yamamoto F; Sasaki S; Mukai T; Yamaguchi H; Ogawa M; Magata Y; Maeda M
    Nucl Med Biol; 2008 Feb; 35(2):203-12. PubMed ID: 18312830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors.
    Kassenbrock A; Vasdev N; Liang SH
    Curr Top Med Chem; 2016; 16(16):1830-42. PubMed ID: 26975506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development.
    Sobrio F; Gilbert G; Perrio C; Barré L; Debruyne D
    Mini Rev Med Chem; 2010 Aug; 10(9):870-86. PubMed ID: 20504276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(3-azidophenyl)-N-methyl-N'-([4-1H]- and [4-3H]-1-naphthyl)guanidine. A potent and selective ligand designed as a photoaffinity label for the phencyclidine site of the N-methyl-D-aspartate receptor.
    Gee KR; Durant GJ; Holmes DL; Magar SS; Weber E; Wong ST; Keana JF
    Bioconjug Chem; 1993; 4(3):226-9. PubMed ID: 8324013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of new beta1-selective adrenoceptor ligands as potential radioligands for in vivo imaging.
    Kopka K; Wagner S; Riemann B; Law MP; Puke C; Luthra SK; Pike VW; Wichter T; Schmitz W; Schober O; Schäfers M
    Bioorg Med Chem; 2003 Aug; 11(16):3513-27. PubMed ID: 12878144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring.
    Bonifazi A; Del Bello F; Mammoli V; Piergentili A; Petrelli R; Cimarelli C; Pellei M; Schepmann D; Wünsch B; Barocelli E; Bertoni S; Flammini L; Amantini C; Nabissi M; Santoni G; Vistoli G; Quaglia W
    J Med Chem; 2015 Nov; 58(21):8601-15. PubMed ID: 26430967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of [(18)F]PK-209, a new PET ligand for imaging the ion-channel site of NMDA receptors.
    Golla SS; Klein PJ; Bakker J; Schuit RC; Christiaans JA; van Geest L; Kooijman EJ; Oropeza-Seguias GM; Langermans JA; Leysen JE; Boellaard R; Windhorst AD; van Berckel BN; Metaxas A
    Nucl Med Biol; 2015 Feb; 42(2):205-12. PubMed ID: 25451213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161.
    Dhawan V; Robeson W; Bjelke D; Chaly T; Graf K; Hellman M; Zhuo L; Mackay M; Eidelberg D
    J Nucl Med; 2015 Jun; 56(6):869-72. PubMed ID: 25931480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, radiosynthesis, and biological evaluation of fluorinated thienylcyclohexyl piperidine derivatives as potential radiotracers for the NMDA receptor-linked calcium ionophore.
    Ouyang X; Mukherjee J; Yang ZY
    Nucl Med Biol; 1996 Apr; 23(3):315-24. PubMed ID: 8782243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 1-(1-[5-(2'-[18F]fluoroethyl)-2-thienyl]-cyclohexyl)piperidine as a potential in vivo radioligand for the NMDA receptor-channel complex.
    Orita K; Sasaki S; Maeda M; Hashimoto A; Nishikawa T; Yugami T; Umezu K
    Nucl Med Biol; 1993 Oct; 20(7):865-73. PubMed ID: 8241999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.